Tonix Pharmaceuticals Holding (FRA:TPM0) 3-Year EBITDA Growth Rate : 60.30% (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Tonix Pharmaceuticals Holding 3-Year EBITDA Growth Rate?

Tonix Pharmaceuticals Holding's EBITDA per Share for the three months ended in Mar. 2024 was €-1.04.

During the past 3 years, the average EBITDA Per Share Growth Rate was 60.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 78.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Tonix Pharmaceuticals Holding was 90.00% per year. The lowest was 60.30% per year. And the median was 83.45% per year.

Competitive Comparison of Tonix Pharmaceuticals Holding's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Tonix Pharmaceuticals Holding's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tonix Pharmaceuticals Holding's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tonix Pharmaceuticals Holding's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Tonix Pharmaceuticals Holding's 3-Year EBITDA Growth Rate falls into.

Tonix Pharmaceuticals Holding 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Tonix Pharmaceuticals Holding (FRA:TPM0) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Tonix Pharmaceuticals Holding 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Tonix Pharmaceuticals Holding's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Tonix Pharmaceuticals Holding (FRA:TPM0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tonix Pharmaceuticals Holding Corp (FRA:TPM0) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

TNXP:USA

Address

26 Main Street, Suite 101, Chatham, NJ, USA, 07928

Website

https://www.tonixpharma.com

Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on developing therapeutics and vaccines to treat and prevent human disease and alleviate suffering. its portfolio consists of the central nervous system, rare disease, immunology, and infectious disease product candidates. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. CNS product candidate is TNX-102 SL, a proprietary sublingual tablet formulation of cyclobenzaprine (CBP) designed for bedtime administration.

Tonix Pharmaceuticals Holding (FRA:TPM0) Headlines

No Headlines